Institutional investors purchased a net $2.3 million shares of IPXL during the quarter ended March 2014, and now own 81.00% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SWEDBANK ROBUR FONDER AB Bought 598.9 Thousand shares of Impax Laboratories Inc